Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CRISAL Study:Cancer Risk In Secreting Adrenal Lesions

NCT06520111 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT06520111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06520111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CRISAL Study:Cancer Risk In Secreting Adrenal Lesions
Lead sponsor
University of Roma La Sapienza
Phase
Observational
Overall status
Recruiting
Start date
August 27, 2024
Completion date
November 10, 2024
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal incidentaloma, adrenal tumor, surgery